REGENXBIO Inc. (RGNX)
NASDAQ: RGNX · Real-Time Price · USD
9.04
+0.29 (3.31%)
At close: Feb 27, 2026, 4:00 PM EST
9.10
+0.06 (0.69%)
After-hours: Feb 27, 2026, 6:54 PM EST
REGENXBIO Market Cap
REGENXBIO has a market cap or net worth of $457.63 million as of February 27, 2026. Its market cap has increased by 28.30% in one year.
Market Cap
457.63M
Enterprise Value
423.73M
1-Year Change
28.30%
Ranking
Category
Stock Price
$9.04
Market Cap Chart
Since September 17, 2015, REGENXBIO's market cap has decreased from $749.30M to $457.63M, a decrease of -38.93%. That is a compound annual growth rate of -4.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 457.60M | -37.23% |
| Dec 31, 2025 | 729.00M | 90.34% |
| Dec 31, 2024 | 383.00M | -51.50% |
| Dec 29, 2023 | 789.70M | -19.57% |
| Dec 30, 2022 | 981.90M | -29.79% |
| Dec 31, 2021 | 1.40B | -17.57% |
| Dec 31, 2020 | 1.70B | 12.32% |
| Dec 31, 2019 | 1.51B | 0.48% |
| Dec 31, 2018 | 1.50B | 45.18% |
| Dec 29, 2017 | 1.04B | 110.87% |
| Dec 30, 2016 | 491.10M | 12.43% |
| Dec 31, 2015 | 436.80M | -41.71% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Solid Biosciences | 483.82M |
| Invivyd | 477.97M |
| vTv Therapeutics | 473.52M |
| Assembly Biosciences | 471.98M |
| Kyverna Therapeutics | 469.03M |
| Prothena Corporation | 466.73M |
| Lineage Cell Therapeutics | 465.27M |
| Autolus Therapeutics | 455.11M |